31
Shock MUDr. Tomas Hitka II.KAIM LFUK

Shock - uniba.sk · 2020. 3. 24. · •Distributive-due to relative hypovolemia secondary to loss of vascular tone and permeability (anaphylaxis, sepsis, neurogenic shock) Pathophysiology

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

  • ShockMUDr. Tomas Hitka

    II.KAIM LFUK

  • Definition

    Failure to meet tissue demand for oxygen

  • Other definitions

    • Clinical state with characteristic symptoms and signs occurring due to an imbalance between O2 supply and demand which leads to tissue hypoxia

    • Condition, in which circulation fails to meet the metabolic need of the tissue and the same time fails to remove the metabolic waste products.

    • CO inadequate to tissue needs

  • Classification

    • Hypovolemic- due to absolute hypovolemia• Hemorrhagic• Non-hemorrhagic

    • Cardiogenic-due to primary pump failure• Ventricular (MI, cardiomyopathy)• Non-ventricular (valves, malignant arrhythmias)

    • Obstructive- due to extra-cardiac flow impediment • Venous return (tension PNO, T)• Arterial outflow (PE)

    • Distributive-due to relative hypovolemia secondary to loss of vascular tone and permeability (anaphylaxis, sepsis, neurogenic shock)

  • Pathophysiology

  • Stages of shock

    1. Initial- hypoperfusion-hypoxia-cell damage-rising lactate

    2. Compensating- hyperventilation, increased adrenaline, noradrenaline, renine angiotensine

    3. Progressive- further damage to cells

    4. Refractory- failure of vital organs

  • Clinical manifestation

    • CNS: confused, drowsy, comatose

    • CVS: tachycardic ,hypotensive

    • Resp: tachypnoeic

    • Renal: oliguric

    • GIT: ileus, submucosal bleeding

    • Skin:• Hypodynamic: cold, pale, clammy

    • Hyperdynamic: warm, bounding pulse

  • Management

    • A,B,C

    • Optimize O2 delivery

    • Optimize CO and BP

    • Treat underlying pathology

    • Support any organ failure

  • Haemorrhagic shock

  • Cardiogenic shock

  • Cardiogenic shock

    • Inotropic support

    • Intra aortic balloon pump

    • V-A ECMO

    • Treat the cause• Revascularization

    • Transplant

  • Pulmonary embolism

    • obstruction of the pulmonary artery or one of its branches by material (eg, thrombus, tumor, air, or fat)

    • acute PE

    • chronic PE

  • Risk factors

    •Virchow’s triad:• Venous stasis• Vein wall injury• Hypercoagulability of blood

  • Patophysiology

    • PA obstruction =>elevated pulmonary vascular resistance and acute pulmonary HTN=> RV dilatation =>RV systolic failure

    • PA obstruction=> V/Q mismatch- dead space• Hypoxaemia

  • Clinical presentation

    • Symptoms:• Breathlessness 73%

    • Pleuritic chest pain 44%

    • Cough 34%

    • Haemoptysis

    • Syncope

    • Signs: can be absent• Tachypnoea 54%

    • Tachycardia 24%

    • Fever

    • RV dysfunction

    • Shock 8%

    • Signs of DVT

  • Investigations

    • ABG, ECG, CXR

    • D-dimer- useful for exclusion

    • CT PA- 91% accuracy

    • ECHO- RV assessment

    • Doppler ultrasound- search for DVT

    • Leg venography- more sensitive but invasive

  • Management

    • Mild PE- low risk of death and recurence- prevention of futherembolization- LMWH

    • Submassive PE-higher mortality and recurrence - LMWH+strongconsideration for thrombolysis

    • Massive PE- 25-30%mortality- urgent removal of clot+ haemodynamic support

  • Prevention of further embolisation

    • Oral anticoagulation

    • IVC filter

  • Anaphylaxis

    • Type I hypersensitivity reaction- IgE mediated

  • Presentation

    • Cardiovascular collapse 88%

    • Erythema 45%

    • Bronchospasm 36%

    • Angio-edema 24%

    • Rash 13%

    • Urticaria 8.5%

  • Initial treatment

    • Check A,B,C

    • Stop any potential triggers

    • Call for help

    • Maintain the airway, give 100% O2

    • Lay the patient flat with the legs elevated

    • Adrenaline 50 ug i.v. until pressure or bronchospasm improves

    • 0.5-1mg i.m. repeat after 10 min if needed

    • Crystalloids i.v.

  • Secondary treatment

    • Antihistamines: chlorpheniramine 10-20mg i.v.

    • Corticosteroids: HCT 100-300mg i.v.

    • Adrenaline infusion if more than 3 boluses required

    • Add noradrenaline or vasopressine

    • ABG- if acidosis consider bicarbonate 0.5-1mmol/kg

    • Bronchdilators

  • Follow up

    • All patients with life threatening reaction must be admitted to the hospital for 24 h monitoring

    • Take blood 1 h after reaction for a tryptase assay

    • Immunology referral

    • Pt chart label

  • Any questions?